Biblio

Export 20 results:
Author Keyword Title Type [ Year(Desc)]
Filters: Author is Winblad, Bengt  [Clear All Filters]
2016
F. Piazza and Winblad, B., Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?, J Alzheimers Dis, vol. 52, no. 2, pp. 417-20, 2016.
J. Lovas, Fereshtehnejad, S. - M., Cermakova, P., Lundberg, C., Johansson, B., Johansson, K., Winblad, B., Eriksdotter, M., and Religa, D., Assessment and Reporting of Driving Fitness in Patients with Dementia in Clinical Practice: Data from SveDem, the Swedish Dementia Registry., J Alzheimers Dis, vol. 53, no. 2, pp. 631-8, 2016.
W. Tajeddinn, Fereshtehnejad, S. - M., Ahmed, M. Seed, Yoshitake, T., Kehr, J., Shahnaz, T., Milovanovic, M., Behbahani, H., Höglund, K., Winblad, B., Cedazo-Minguez, A., Jelic, V., Järemo, P., and Aarsland, D., Association of Platelet Serotonin Levels in Alzheimer's Disease with Clinical and Cerebrospinal Fluid Markers., J Alzheimers Dis, vol. 53, no. 2, pp. 621-30, 2016.
N. Lelental, Brandner, S., Kofanova, O., Blennow, K., Zetterberg, H., Andreasson, U., Engelborghs, S., Mroczko, B., Gabryelewicz, T., Teunissen, C., Mollenhauer, B., Parnetti, L., Chiasserini, D., Molinuevo, J. Luis, Perret-Liaudet, A., Verbeek, M. M., Andreasen, N., Brosseron, F., Bahl, J. M. C., Herukka, S. - K., Hausner, L., Frölich, L., Labonte, A., Poirier, J., Miller, A. - M., Zilka, N., Kovacech, B., Urbani, A., Suardi, S., Oliveira, C., Baldeiras, I., Dubois, B., Rot, U., Lehmann, S., Skinningsrud, A., Betsou, F., Wiltfang, J., Gkatzima, O., Winblad, B., Buchfelder, M., Kornhuber, J., and Lewczuk, P., Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics., J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D., Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
2017
K. Håkansson, Ledreux, A., Daffner, K., Terjestam, Y., Bergman, P., Carlsson, R., Kivipelto, M., Winblad, B., Granholm, A. - C., and Mohammed, A. Kadir H., BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function., J Alzheimers Dis, vol. 55, no. 2, pp. 645-657, 2017.
R. L. H. Handels, Wimo, A., Dodel, R., Kramberger, M. G., Visser, P. Jelle, Molinuevo, J. Luis, Verhey, F. R. J., and Winblad, B., Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia., J Alzheimers Dis, vol. 60, no. 4, pp. 1477-1487, 2017.
A. - M. Miller, Balasa, M., Blennow, K., Gardiner, M., Rutkowska, A., Scheltens, P., Teunissen, C. E., Visser, P. Jelle, Winblad, B., Waldemar, G., and Lawlor, B., Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe., J Alzheimers Dis, vol. 60, no. 1, pp. 201-210, 2017.
V. Bloniecki, Aarsland, D., Blennow, K., Cummings, J., Falahati, F., Winblad, B., and Freund-Levi, Y., Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid., J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
P. Cermakova, Nelson, M., Secnik, J., Garcia-Ptacek, S., Johnell, K., Fastbom, J., Kilander, L., Winblad, B., Eriksdotter, M., and Religa, D., Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry., J Alzheimers Dis, vol. 58, no. 4, pp. 1265-1272, 2017.
M. G. Kramberger, Auestad, B., Garcia-Ptacek, S., Abdelnour, C., Olmo, J. Garre, Walker, Z., Lemstra, A. W., Londos, E., Blanc, F., Bonanni, L., McKeith, I., Winblad, B., de Jong, F. Jan, Nobili, F., Stefanova, E., Petrova, M., Falup-Pecurariu, C., Rektorova, I., Bostantjopoulou, S., Biundo, R., Weintraub, D., and Aarsland, D., Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort., J Alzheimers Dis, vol. 57, no. 3, pp. 787-795, 2017.
2021
J. Cummings, Schwartz, G. G., Nicholls, S. J., Khan, A., Halliday, C., Toth, P. P., Sweeney, M., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Lebioda, K., Ginsberg, H. N., Winblad, B., Zetterberg, H., and Ray, K. K., Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial., J Alzheimers Dis, vol. 83, no. 4, pp. 1703-1715, 2021.
A. Wimo, Belger, M., Bon, J., Jessen, F., Dumas, A., Kramberger, M. G., Jamilis, L., Johansson, G., Salas, A. Rodrigo, Gómez, O. Rodríguez, Sannemann, L., Stoekenbroek, M., Telleria, M. Gurruchaga, Valero, S., Vermunt, L., Waterink, L., Winblad, B., Visser, P. Jelle, Zwan, M., and Boada, M., A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project., J Alzheimers Dis, vol. 83, no. 3, pp. 1149-1159, 2021.
E. Zupanic, von Euler, M., Winblad, B., Xu, H., Secnik, J., Kramberger, M. Gregoric, Religa, D., Norrving, B., and Garcia-Ptacek, S., Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders., J Alzheimers Dis, vol. 81, no. 3, pp. 1253-1261, 2021.
A. Speh, Wang, R., Winblad, B., Kramberger, M. G., Bäckman, L., Qiu, C., and Laukka, E. J., The Relationship Between Cardiovascular Health and Rate of Cognitive Decline in Young-Old and Old-Old Adults: A Population-Based Study., J Alzheimers Dis, vol. 84, no. 4, pp. 1523-1537, 2021.
Y. Yu, Gao, Y., Winblad, B., Tjernberg, L. O., and Schedin-Weiss, S., A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons., J Alzheimers Dis, vol. 83, no. 2, pp. 833-852, 2021.
U. Smailovic, Kåreholt, I., Koenig, T., Ashton, N. J., Winblad, B., Höglund, K., Nilsson, P., Zetterberg, H., Blennow, K., and Jelic, V., Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease., J Alzheimers Dis, vol. 83, no. 1, pp. 355-366, 2021.